written by reader Matt McCall’s pitch on Cas9 treatment and testing platform

By ABL40, May 12, 2021

Does anyone know the leading company Matt McCall is pitching specific to CRISPR Cas9 genetic testing? Apparently this one entity has the IP where their technology must be licensed for others to use their testing platform.

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Inline Feedbacks
View all comments